Celiac Disease: Developing Drugs for Adjunctive Treatment to a Gluten-Free Diet]; Draft Guidance for Industry; Availability | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

Open for Comments

FDA-2021-D-1238

Celiac Disease: Developing Drugs for Adjunctive Treatment to a Gluten-Free Diet]; Draft Guidance for Industry; Availability

Documents

Comments

Description

CLOSED

Key Dates

Comment Period OpensApr 15, 2022

Comment Period ClosesJun 15, 2022

Documents

Type	Title	Posted	Comments	Status
Notice	Celiac Disease: Developing Drugs for Adjunctive Treatment to a Gluten-Free Diet; Draft Guidance for Industry; Availability FR Doc: 2022-08116	Apr 15, 2022	18

Comment Statistics

Total Comments

Keywords

OPEN

CDER

Guidance for Industry; Availability

to a Gluten-Free Diet]; Draft

for Adjunctive Treatment

Celiac Disease: Developing Drugs

Data from Regulations.gov